Foreword
Boston MA, U.S.A.
References
- Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation. 1999;99:2720–2732
[Abstract/Free Full Text] - Antman EM, Gibson CM, de Lemos JA, et al. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. Eur Heart J. 2000;21:1944–1953
[Abstract/Free Full Text] - SPEED Group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation. 2000;101:2788–2794
[Abstract/Free Full Text] - de Lemos JA, Antman EM, Gibson CM, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: observations from the TIMI 14 trial. Circulation. 2000;101:239–243
[Abstract/Free Full Text] - de Lemos JA, Antman EA, Giugliano RP, et al. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol. 2000;85:299–304[CrossRef][Web of Science][Medline]
- Neumann FJ, Kosa I, Dickfield T, et al. Recovery of myocardial perfusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarct-related coronary artery. J Am Coll Cardiol. 1997;30:1270–1276[Abstract]
- Neumann F-J, Zolnhöfer D, Fakhoury L, Ott I, Gawaz M, Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420–1426
[Abstract/Free Full Text] - Neumann F-J, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695–2701
[Abstract/Free Full Text] - Neumann F-J, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol. 2000;35:915–921
[Abstract/Free Full Text] - EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with glycoprotein-IIb/IIIa blockade. Lancet. 1998;35:87–92[CrossRef]
- Tcheng J. ESPRIT dta, presented at the 23rd Annual Meeting of the Society for Cardiac Angiography and Intervention. May 2000. Charleston, SC, U.S.A.
- The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet. 2000;356:2037–2044[CrossRef][Web of Science][Medline]
- Brener SJ, Barr LA, Burchenal JE, et al. on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) InvestigatorsCirculation. 1998;98:734–741
[Abstract/Free Full Text] - Stone GW. CADILLAC trial results, presented at Transcatheter Cardiovascular Therapeutics 2000. October 17–22, 2000. Washington, DC, U.S.A.
- Montalescot G, Barragan P, Wittenberg O, et al. Abciximab associated with primary angioplasty and stenting in acute myocardia infarction: the ADMIRAL study, 30 day final results (Abstr.). Circulation. 1999;100(Suppl I):I–87
- Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 pilot) trial. J Am Coll Cardiol. 2000;36:1489–1496
[Abstract/Free Full Text] - The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997;349:1429–1435[CrossRef][Web of Science][Medline]
- The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 1998;338:1498–1505
[Abstract/Free Full Text] - The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 1997;96:1445–1453
[Abstract/Free Full Text] - Hamm CW, Heeschen C, Goldman B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin levels. N Engl J Med. 1999;340:1623–1629
[Abstract/Free Full Text] - Simoons M. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IV-ACS). Presented at the 22nd Annual Congress of the European Society of Cardiology. August 26–30, 2000. Amsterdam, The Netherlands
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||